Epitherapy and Immune Checkpoint Blockade: Using Epigenetic Reinvigoration of Exhausted and Dysfunctional T Cells to Reimburse Immunotherapy Response
BMC Immunology - United Kingdom
doi 10.1186/s12865-020-00353-0
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 21, 2020
Authors
Publisher
Springer Science and Business Media LLC